ConductScience.org, home

Paper348261

Bromocriptine in Parkinsonism.

Pearce I and 1 other. Br Med J, 1978. Cited by 31 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Bromocriptine in Parkinsonism. Papers, record 348261. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/348261

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Bromocriptine in Parkinsonism.
PubMed
Journal
Br Med J
PubMed
Year
1978
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
31
iCite
Relative citation ratio, by iCite
1.82
iCite
Revised in PubMed
2019-05-01
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pearce II
2Pearce JMJ M

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BromocriptineMajor topic
Parkinson DiseaseMajor topic
Drug Evaluation
Drug Therapy, Combination
Humans
Levodopa
Psychoses, Substance-Induced

Source PubMed

References12

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1330,825Comparison of the effects of bromocriptine and levodopa in Parkinson's disease.J Neurol Neurosurg Psychiatry1977https://conductscience.org/library/papers/330825PubMed
2912,157Bromocriptine.Br J Hosp Med1977https://conductscience.org/library/papers/912157PubMed
31,036,999Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa.J Neurol Neurosurg Psychiatry1976https://conductscience.org/library/papers/1036999PubMed
4989,885Treatment of parkinson's disease with bromocriptine.N Engl J Med1976https://conductscience.org/library/papers/989885PubMed
54,126,558Sustained levodopa therapy in parkinsonism.Lancet1973https://conductscience.org/library/papers/4126558PubMed
648,873Letter: Parkinsonism and dementia: effects of levodopa.Lancet1975https://conductscience.org/library/papers/48873PubMed
759,850Bromocriptine and levodopa (with or without carbidopa) in parkinsonism.Lancet1976https://conductscience.org/library/papers/59850PubMed
853,655Bromocriptine therapy in acromegaly.Lancet1975https://conductscience.org/library/papers/53655PubMed
94,945,017Current concepts of Parkinsonism.Postgrad Med J1971https://conductscience.org/library/papers/4945017PubMed
10812,004On-off response. Clinical and biochemical correlations during oral and intravenous levodopa administration in parkinsonian patients.Neurology1975https://conductscience.org/library/papers/812004PubMed
11773,080Effect of CB 154 (2-bromo-alpha-ergocryptine) on paralysis agitans compared with Madopar in a double-blind, cross-over trial.Acta Neurol Scand1976https://conductscience.org/library/papers/773080PubMed
12943,193Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.Br J Pharmacol1976https://conductscience.org/library/papers/943193PubMed

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.

PMIDTitleJournalYearIn PapersSource
7,428,799Bromocriptine concentration in saliva plasma after long-term treatment of patients with Parkinson's disease.Eur J Clin Pharmacol1980https://conductscience.org/library/papers/7428799PubMed
6,882,030Gas-liquid chromatographic analysis of synovial fluid: volatile short-chain fatty acids in septic arthritis.Ann Rheum Dis1983https://conductscience.org/library/papers/6882030PubMed
6,861,794Fate and disposition of bromocriptine in animals and man. II: Absorption, elimination and metabolism.Eur J Drug Metab Pharmacokinet1983https://conductscience.org/library/papers/6861794PubMed
6,188,812Long-term experience with bromocriptine in advanced parkinsonism. Results after one year's treatment.J Neurol1982https://conductscience.org/library/papers/6188812PubMed
6,180,142Adjuvant treatment of Parkinson's disease with dopamine agonists: open trial with bromocriptine and CU 32-085.J Neurol1982https://conductscience.org/library/papers/6180142PubMed
3,998,746Low-dose bromocriptine in Parkinson's disease.J Neurol Neurosurg Psychiatry1985https://conductscience.org/library/papers/3998746PubMed
2,651,567Bromocriptine in Parkinson's disease: a double-blind study comparing "low-slow" and "high-fast" introductory dosage regimens in de novo patients. UK Bromocriptine Research Group.J Neurol Neurosurg Psychiatry1989https://conductscience.org/library/papers/2651567PubMed
477,712Pharmacokinetics of bromocriptine during continuous oral treatment of Parkinson's disease.Eur J Clin Pharmacol1979https://conductscience.org/library/papers/477712PubMed
365,210Dopamine agonists for negative symptoms in schizophrenia.Br J Clin Pharmacol1978https://conductscience.org/library/papers/365210PubMed
32,952Aetiology and natural history of Parkinson's disease.Br Med J1978https://conductscience.org/library/papers/32952PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/348261

GET https://conductscience.org/api/papers/v1/348261/authors